Bioequivalence and Food Effect Assessment of 2 Fixed‐Dose Combination Formulations of Dolutegravir and Lamivudine

This single‐dose study evaluated the bioequivalence, food effect, and safety of 2 experimental, 2‐drug, fixed‐dose formulations of 50 mg dolutegravir and 300 mg lamivudine (formulation AH and formulation AK) as compared with coadministration of single‐entity tablets of 50 mg dolutegravir and 300 mg...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Pharmacol Drug Dev
Main Authors: Dumitrescu, Teodora Pene, Peddiraju, Kavita, Fu, Caifeng, Bakshi, Kalpana, Yu, Shui, Zhang, Zhiping, Tenorio, Allan R., Spancake, Chris, Joshi, Shashidhar, Wolstenholme, Allen, Adkison, Kimberly
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028125/
https://ncbi.nlm.nih.gov/pubmed/31724343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.740
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares